{"name":"GLP-1 telehealth programs with FDA warning letters","statistic":"5 of the 37 GLP-1 telehealth programs we track have received an FDA warning letter naming a GLP-1 drug; FDA has sent 110 such letters filed as telehealth cases since September 2025, per FDA's warning-letter index read October 3, 2026.","figure":"5 of 37","figure_label":"tracked programs with an FDA warning letter","source_as_of":"2026-10-03","source_as_of_label":"FDA index read","read":"2026-10-03","temporal_coverage":"2025-09-09/2026-10-03","page":"https://pricetrackerglp1.com/data/telehealth-programs-with-fda-warning-letters","license":"CC BY 4.0: cite PriceTracker GLP-1, pricetrackerglp1.com","license_url":"https://creativecommons.org/licenses/by/4.0/","based_on":["https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters"],"method":{"computed":"Numerator: programs on our board that are the hand-confirmed recipient of at least one FDA warning letter naming a GLP-1 drug. Denominator: every program on our board (37), live or paused. The telehealth total counts letters whose FDA subject line says \"Telehealth\".","include":["Every program on our board, including paused ones; hidden programs have no page and are not counted.","Letters of any subject to a program we track, not only telehealth-filed ones."],"exclude":["Programs we do not track: FDA's telehealth letters went to many sellers we have never listed.","Letters to the pharmacies or clinicians behind a program, unless the program itself is the recipient."],"caveats":["A warning letter is FDA's allegation and a request to respond; it is not a court finding.","We list only programs we partner with. A letter does not remove a program from our board; its page shows the letter.","FDA's subject lines for the telehealth letters: \"False & Misleading Claims/Misbranded\" (55), \"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet\" (55)."]},"columns":[{"key":"recipient","label":"Recipient","type":"text"},{"key":"letter_date","label":"Letter date","type":"date"},{"key":"program_we_track","label":"Program we track","type":"text"},{"key":"drugs_named","label":"Drugs named","type":"text"},{"key":"subject","label":"FDA subject","type":"text"},{"key":"closeout","label":"Closeout","type":"text"},{"key":"fda_url","label":"FDA letter","type":"text"}],"rows":[{"recipient":"Maximus Health, Inc. dba Maximus","letter_date":"2026-06-08","program_we_track":"Maximus","drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maximus-health-inc-dba-maximus-730095-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/maximus-health-inc-dba-maximus-730095","program_url":"https://pricetrackerglp1.com/p/maximus"},{"recipient":"Ivim Services LLC dba Ivim","letter_date":"2026-02-20","program_we_track":"Ivim Health","drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ivim-services-llc-dba-ivim-721816-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/ivim-services-llc-dba-ivim-721816","program_url":"https://pricetrackerglp1.com/p/ivim-health"},{"recipient":"Lean Rx, Inc. dba SkinnyRx","letter_date":"2026-02-20","program_we_track":"SkinnyRx","drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lean-rx-inc-dba-skinnyrx-717989-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/lean-rx-inc-dba-skinnyrx-717989","program_url":"https://pricetrackerglp1.com/p/skinnyrx"},{"recipient":"Strut Health, LLC dba Strut","letter_date":"2026-02-20","program_we_track":"Strut Health","drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/strut-health-llc-dba-strut-721448-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/strut-health-llc-dba-strut-721448","program_url":"https://pricetrackerglp1.com/p/strut-health"},{"recipient":"Sprout Health Partners LLC dba Sprout Health","letter_date":"2025-09-09","program_we_track":"Sprout Health","drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/sprout-health-partners-llc-dba-sprout-health-715879-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/sprout-health-partners-llc-dba-sprout-health-715879","program_url":"https://pricetrackerglp1.com/p/sprout-health"},{"recipient":"Altru Telehealth, LLC dba Altru Telehealth","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/altru-telehealth-llc-dba-altru-telehealth-728274-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/altru-telehealth-llc-dba-altru-telehealth-728274","program_url":null},{"recipient":"Amie Health, Inc. dba Amie","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amie-health-inc-dba-amie-728276-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/amie-health-inc-dba-amie-728276","program_url":null},{"recipient":"Clover Meds LLC dba Clover Meds","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/clover-meds-llc-dba-clover-meds-728234-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/clover-meds-llc-dba-clover-meds-728234","program_url":null},{"recipient":"D&H Medical Services","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dh-medical-services-728238-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/d-and-h-medical-services-728238","program_url":null},{"recipient":"Eden Health International Inc. dba Eden","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/eden-health-international-inc-dba-eden-728279-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/eden-health-international-inc-dba-eden-728279","program_url":null},{"recipient":"Ezra Holdco LLC dba Ezra","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ezra-holdco-llc-dba-ezra-730995-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/ezra-holdco-llc-dba-ezra-730995","program_url":null},{"recipient":"FITISH","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitish-728280-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/fitish-728280","program_url":null},{"recipient":"FitRX, LLC dba AM RX","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-am-rx-728275-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/fitrx-llc-dba-am-rx-728275","program_url":null},{"recipient":"Glow Medispa, LLC dba Mint Med","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glow-medispa-llc-dba-mint-med-730390-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/glow-medispa-llc-dba-mint-med-730390","program_url":null},{"recipient":"HydraMed IV LLC dba HydraMed","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hydramed-iv-llc-dba-hydramed-728282-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/hydramed-iv-llc-dba-hydramed-728282","program_url":null},{"recipient":"Joi and Blokes dba Joi + Blokes","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/joi-and-blokes-dba-joi-blokes-728283-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/joi-and-blokes-dba-joi-blokes-728283","program_url":null},{"recipient":"Medica Weight Loss","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medica-weight-loss-728284-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/medica-weight-loss-728284","program_url":null},{"recipient":"Momentum Health 360 dba Momentum Health","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide, Liraglutide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/momentum-health-360-dba-momentum-health-728286-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/momentum-health-360-dba-momentum-health-728286","program_url":null},{"recipient":"NativeMed LLC dba NativeMed","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nativemed-llc-dba-nativemed-728287-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/nativemed-llc-dba-nativemed-728287","program_url":null},{"recipient":"Nexlife Inc. dba Nexlife","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexlife-inc-dba-nexlife-730096-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/nexlife-inc-dba-nexlife-730096","program_url":null},{"recipient":"Nexus Health Solutions LLC dba Harper Meds","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nexus-health-solutions-llc-dba-harper-meds-728281-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/nexus-health-solutions-llc-dba-harper-meds-728281","program_url":null},{"recipient":"Nova Vascular LLC dba NOVARX","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nova-vascular-llc-dba-novarx-728290-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/nova-vascular-llc-dba-novarx-728290","program_url":null},{"recipient":"OrderlyMeds LLC dba OrderlyMeds","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/orderlymeds-llc-dba-orderlymeds-728291-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/orderlymeds-llc-dba-orderlymeds-728291","program_url":null},{"recipient":"Public Health Solution LLC dba DrMedHealth","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/public-health-solution-llc-dba-drmedhealth-728278-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/public-health-solution-llc-dba-drmedhealth-728278","program_url":null},{"recipient":"Ready Med","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ready-med-730317-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/ready-med-730317","program_url":null},{"recipient":"Roen Health, Inc. dba RoenRx","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/roen-health-inc-dba-roenrx-728293-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/roen-health-inc-dba-roenrx-728293","program_url":null},{"recipient":"Thrivelab Co. dba Thrivelab","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/thrivelab-co-dba-thrivelab-728294-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/thrivelab-co-dba-thrivelab-728294","program_url":null},{"recipient":"Trinity HealthCare Supply, LLC dba altRx","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trinity-healthcare-supply-llc-dba-altrx-728236-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/trinity-healthcare-supply-llc-dba-altrx-728236","program_url":null},{"recipient":"VivioMD Group LLC dba VivioMD","letter_date":"2026-06-08","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/viviomd-group-llc-dba-viviomd-728295-06082026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/viviomd-group-llc-dba-viviomd-728295","program_url":null},{"recipient":"24HrDoc, Inc. dba 24HrDoc","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/24hrdoc-inc-dba-24hrdoc-717984-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/24hrdoc-inc-dba-24hrdoc-717984","program_url":null},{"recipient":"Alan Health Technologies Inc. dba Alan","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/alan-health-technologies-inc-dba-alan-721814-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/alan-health-technologies-inc-dba-alan-721814","program_url":null},{"recipient":"Aspen Aesthetics dba Fifty 410","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/aspen-aesthetics-dba-fifty-410-721481-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/aspen-aesthetics-dba-fifty-410-721481","program_url":null},{"recipient":"Belle Health LLC dba Belle","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/belle-health-llc-dba-belle-721795-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/belle-health-llc-dba-belle-721795","program_url":null},{"recipient":"Better Health Labs, Inc. dba Measured","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/better-health-labs-inc-dba-measured-721454-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/better-health-labs-inc-dba-measured-721454","program_url":null},{"recipient":"Bliv Wellness LLC dba Bliv","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bliv-wellness-llc-dba-bliv-721479-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/bliv-wellness-llc-dba-bliv-721479","program_url":null},{"recipient":"BluefitMD","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bluefitmd-721446-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/bluefitmd-721446","program_url":null},{"recipient":"Deluxe IV Aesthetics PLLC dba Deluxe IV and Aesthetics","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/deluxe-iv-aesthetics-pllc-dba-deluxe-iv-and-aesthetics-721447-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/deluxe-iv-aesthetics-pllc-dba-deluxe-iv-and-aesthetics-721447","program_url":null},{"recipient":"Dripgym Mobile Parent, LLC dba Amp Health","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dripgym-mobile-parent-llc-dba-amp-health-717992-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/dripgym-mobile-parent-llc-dba-amp-health-717992","program_url":null},{"recipient":"FitRX, LLC dba FitRx","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-fitrx-717987-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/fitrx-llc-dba-fitrx-717987","program_url":null},{"recipient":"Genesis Health International Inc. dba Genesis","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/genesis-health-international-inc-dba-genesis-721451-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/genesis-health-international-inc-dba-genesis-721451","program_url":null},{"recipient":"Good Girl LLC dba GoodGirlRX","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/good-girl-llc-dba-goodgirlrx-721449-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/good-girl-llc-dba-goodgirlrx-721449","program_url":null},{"recipient":"Join Josie","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/join-josie-717986-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/join-josie-717986","program_url":null},{"recipient":"Kare Solutions, LLC dba Zappy","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide, Liraglutide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kare-solutions-llc-dba-zappy-717991-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/kare-solutions-llc-dba-zappy-717991","program_url":null},{"recipient":"Kin Meds","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/kin-meds-721450-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/kin-meds-721450","program_url":null},{"recipient":"Levity Inc. dba Levity","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Liraglutide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/levity-inc-dba-levity-717990-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/levity-inc-dba-levity-717990","program_url":null},{"recipient":"MaxLife Technologies Inc. dba Maxlife","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/maxlife-technologies-inc-dba-maxlife-721453-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/maxlife-technologies-inc-dba-maxlife-721453","program_url":null},{"recipient":"MEDVi, LLC dba MEDVi","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medvi-llc-dba-medvi-721455-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/medvi-llc-dba-medvi-721455","program_url":null},{"recipient":"Newman Clinic, PLLC dba Newman Clinic","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/newman-clinic-pllc-dba-newman-clinic-721470-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/newman-clinic-pllc-dba-newman-clinic-721470","program_url":null},{"recipient":"NewSelf Limited dba NewSelf","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/newself-limited-dba-newself-721472-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/newself-limited-dba-newself-721472","program_url":null},{"recipient":"Peaks Curative, LLC dba Peaks","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peaks-curative-llc-dba-peaks-721817-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/peaks-curative-llc-dba-peaks-721817","program_url":null},{"recipient":"PharmaZee","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/pharmazee-721473-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/pharmazee-721473","program_url":null},{"recipient":"Premium Health Management Inc. dba Premium Health","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/premium-health-management-inc-dba-premium-health-721474-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/premium-health-management-inc-dba-premium-health-721474","program_url":null},{"recipient":"Refills Health, LLC dba Refills Health","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/refills-health-llc-dba-refills-health-721475-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/refills-health-llc-dba-refills-health-721475","program_url":null},{"recipient":"Viv Health, Inc. dba VIV RX","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/viv-health-inc-dba-viv-rx-721818-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/viv-health-inc-dba-viv-rx-721818","program_url":null},{"recipient":"Weightless Medical LLC dba WeightCare","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/weightless-medical-llc-dba-weightcare-721478-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/weightless-medical-llc-dba-weightcare-721478","program_url":null},{"recipient":"Zeuss LLC dba Zeuss","letter_date":"2026-02-20","program_we_track":null,"drugs_named":"Tirzepatide","subject":"False & Misleading Claims/Misbranded (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/zeuss-llc-dba-zeuss-717985-02202026","record_url":"https://pricetrackerglp1.com/safety/warning-letters/zeuss-llc-dba-zeuss-717985","program_url":null},{"recipient":"All American Wellness","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/all-american-wellness-715991-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/all-american-wellness-715991","program_url":null},{"recipient":"Amazing Meds","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Retatrutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/amazing-meds-715506-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/amazing-meds-715506","program_url":null},{"recipient":"ASN-LABS","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide, Retatrutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/asn-labs-716459-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/asn-labs-716459","program_url":null},{"recipient":"Bioverse, Inc. dba Bioverse","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/bioverse-inc-dba-bioverse-716508-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/bioverse-inc-dba-bioverse-716508","program_url":null},{"recipient":"Body Good Studio","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/body-good-studio-716460-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/body-good-studio-716460","program_url":null},{"recipient":"Canada Med Stop","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/canada-med-stop-716517-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/canada-med-stop-716517","program_url":null},{"recipient":"Cosmo Medical Spa dba Cosmo Med Spa","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/cosmo-medical-spa-dba-cosmo-med-spa-715873-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/cosmo-medical-spa-dba-cosmo-med-spa-715873","program_url":null},{"recipient":"Curex","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/curex-716821-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/curex-716821","program_url":null},{"recipient":"directmeds.com, Inc. dba DirectMeds","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/directmedscom-inc-dba-directmeds-716822-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/directmeds-com-inc-dba-directmeds-716822","program_url":null},{"recipient":"Dr. Gater’s Weight Loss & Wellness","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/dr-gaters-weight-loss-wellness-712866-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/dr-gater-s-weight-loss-and-wellness-712866","program_url":null},{"recipient":"EA WORKS Limited Liability Company dba Trust Labs","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide, Retatrutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ea-works-limited-liability-company-dba-trust-labs-715798-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/ea-works-limited-liability-company-dba-trust-labs-715798","program_url":null},{"recipient":"eDrugstore","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/edrugstore-716505-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/edrugstore-716505","program_url":null},{"recipient":"Elevate Your Wellness LLC, dba Elevated","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/elevate-your-wellness-llc-dba-elevated-719811-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/elevate-your-wellness-llc-dba-elevated-719811","program_url":null},{"recipient":"Elite Health Center","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/elite-health-center-715869-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/elite-health-center-715869","program_url":null},{"recipient":"EvoLife Wellness","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/evolife-wellness-715507-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/evolife-wellness-715507","program_url":null},{"recipient":"Expert Aesthetics","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/expert-aesthetics-715796-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/expert-aesthetics-715796","program_url":null},{"recipient":"Fancy Meds, LLC dba Fancy Meds","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fancy-meds-llc-dba-fancy-meds-716487-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/fancy-meds-llc-dba-fancy-meds-716487","program_url":null},{"recipient":"FitRX, LLC dba Zealthy","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fitrx-llc-dba-zealthy-716501-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/fitrx-llc-dba-zealthy-716501","program_url":null},{"recipient":"FWD Care, Inc. dba FWD","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fwd-care-inc-dba-fwd-716696-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/fwd-care-inc-dba-fwd-716696","program_url":null},{"recipient":"GenLabMeds","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide, Retatrutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/genlabmeds-713650-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/genlabmeds-713650","program_url":null},{"recipient":"Get.Fit.Medical, LLC dba Get.Fit.Medical","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/getfitmedical-llc-dba-getfitmedical-715801-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/get-fit-medical-llc-dba-get-fit-medical-715801","program_url":null},{"recipient":"GLP-1 Solution","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide, Retatrutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/glp-1-solution-715883-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/glp-1-solution-715883","program_url":null},{"recipient":"HealBerry","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healberry-719809-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/healberry-719809","program_url":null},{"recipient":"Healthon Inc. dba Healthon","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthon-inc-dba-healthon-719809-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/healthon-inc-dba-healthon-719809","program_url":null},{"recipient":"Healthy Living Clinic","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthy-living-clinic-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/healthy-living-clinic","program_url":null},{"recipient":"Healthy Male","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/healthy-male-716506-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/healthy-male-716506","program_url":null},{"recipient":"Hims & Hers Health, Inc. dba Hers","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hers-716825-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/hims-and-hers-health-inc-dba-hers-716825","program_url":null},{"recipient":"Hims & Hers Health, Inc. dba Hims","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hims-hers-health-inc-dba-hims-716567-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/hims-and-hers-health-inc-dba-hims-716567","program_url":null},{"recipient":"inspire.clinic","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/inspireclinic-715799-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/inspire-clinic-715799","program_url":null},{"recipient":"Intimate Rose","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/intimate-rose-716458-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/intimate-rose-716458","program_url":null},{"recipient":"Invigorate Med Spa","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/invigorate-med-spa-715872-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/invigorate-med-spa-715872","program_url":null},{"recipient":"iVisitDoc, Inc. dba iVisitDoc","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ivisitdoc-inc-dba-ivisitdoc-716826-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/ivisitdoc-inc-dba-ivisitdoc-716826","program_url":null},{"recipient":"JulyMD","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/julymd-716828-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/julymd-716828","program_url":null},{"recipient":"Las Villas Health Care LLC dba Villas Health","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/las-villas-health-care-llc-dba-villas-health-716504-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/las-villas-health-care-llc-dba-villas-health-716504","program_url":null},{"recipient":"Lean Dreams LLC dba LeanDreams","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lean-dreams-llc-dba-leandreams-716697-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/lean-dreams-llc-dba-leandreams-716697","program_url":null},{"recipient":"Lovely Meds, Inc. dba Lovely Meds","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lovely-meds-inc-dba-lovely-meds-716829-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/lovely-meds-inc-dba-lovely-meds-716829","program_url":null},{"recipient":"Lumimeds","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lumimeds-716510-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/lumimeds-716510","program_url":null},{"recipient":"Lyfe Rx","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/lyfe-rx-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/lyfe-rx","program_url":null},{"recipient":"Mane & Steel, LLC. dba Mane & Steel","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/mane-steel-llc-dba-mane-steel-716455-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/mane-and-steel-llc-dba-mane-and-steel-716455","program_url":null},{"recipient":"Master Pharmaceuticals Group","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/master-pharmaceuticals-group-715800-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/master-pharmaceuticals-group-715800","program_url":null},{"recipient":"Matthew Stern, CEO MyStart Health LLC.","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/matthew-stern-ceo-mystart-health-llc-714755-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/matthew-stern-ceo-mystart-health-llc-714755","program_url":null},{"recipient":"MedClub by Dr. Jenn","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Retatrutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/medclub-dr-jenn-712126-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/medclub-by-dr-jenn-712126","program_url":null},{"recipient":"Nuvo Life Health Inc. dba Nuvo Life Health","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/nuvo-life-health-inc-dba-nuvo-life-health-715794-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/nuvo-life-health-inc-dba-nuvo-life-health-715794","program_url":null},{"recipient":"Remedy Meds","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/remedy-meds-716830-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/remedy-meds-716830","program_url":null},{"recipient":"Reset IV, LLC dba Reset IV","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/reset-iv-llc-dba-reset-iv-716488-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/reset-iv-llc-dba-reset-iv-716488","program_url":null},{"recipient":"SemaBio","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/semabio-715866-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/semabio-715866","program_url":null},{"recipient":"SimpleRx","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/simplerx-715874-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/simplerx-715874","program_url":null},{"recipient":"Slendid","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/slendid-716700-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/slendid-716700","program_url":null},{"recipient":"The HCG Institute","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/hcg-institute-716512-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/the-hcg-institute-716512","program_url":null},{"recipient":"Try Nova","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/try-nova-716695-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/try-nova-716695","program_url":null},{"recipient":"TRYM Health, Inc. dba TRYM Health","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/trym-health-inc-dba-trym-health-716699-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/trym-health-inc-dba-trym-health-716699","program_url":null},{"recipient":"Tuyo Health, Inc. dba Tuyo Health","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/tuyo-health-inc-dba-tuyo-health-716502-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/tuyo-health-inc-dba-tuyo-health-716502","program_url":null},{"recipient":"Vitals RX","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/vitals-rx-715868-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/vitals-rx-715868","program_url":null},{"recipient":"ybycmeds","letter_date":"2025-09-09","program_we_track":null,"drugs_named":"Semaglutide, Tirzepatide","subject":"Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)","closeout":null,"fda_url":"https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/ybycmeds-715878-09092025","record_url":"https://pricetrackerglp1.com/safety/warning-letters/ybycmeds-715878","program_url":null}]}